Phase 1 dose escalation trial of ilorasertib, a dual Aurora/VEGF receptor kinase inhibitor, in patients with hematologic malignancies

Overview of attention for article published in Investigational New Drugs, May 2015

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 19 Dimensions

Readers on

mendeley: 35 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 28,230 followers.

A phase 1 trial of aurora kinase ilorasertib in leukemia http://t.co/2VLM4vKzQp http://t.co/F2pxJl7wgD

Reply Repost Favourite

A phase 1 trial of aurora kinase ilorasertib in leukemia http://t.co/2VLM4vKzQp http://t.co/F2pxJl7wgD

Reply Repost Favourite